BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32487609)

  • 1. Six Candidate miRNAs Associated With Early Relapse in Pediatric B-Cell Acute Lymphoblastic Leukemia.
    Amankwah EK; Devidas M; Teachey DT; Rabin KR; Brown PA
    Anticancer Res; 2020 Jun; 40(6):3147-3153. PubMed ID: 32487609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
    Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
    Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia.
    Avigad S; Verly IR; Lebel A; Kordi O; Shichrur K; Ohali A; Hameiri-Grossman M; Kaspers GJ; Cloos J; Fronkova E; Trka J; Luria D; Kodman Y; Mirsky H; Gaash D; Jeison M; Avrahami G; Elitzur S; Gilad G; Stark B; Yaniv I
    Genes Chromosomes Cancer; 2016 Apr; 55(4):328-39. PubMed ID: 26684414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia].
    Xu L; Liang YN; Luo XQ; Liu XD; Guo HX
    Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):178-81. PubMed ID: 21535956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL.
    Han BW; Feng DD; Li ZG; Luo XQ; Zhang H; Li XJ; Zhang XJ; Zheng LL; Zeng CW; Lin KY; Zhang P; Xu L; Chen YQ
    Hum Mol Genet; 2011 Dec; 20(24):4903-15. PubMed ID: 21926415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of microRNA profiling data does not reveal a consensus signature for B cell acute lymphoblastic leukemia.
    Longjohn MN; Squires WRB; Christian SL
    Gene; 2022 May; 821():146211. PubMed ID: 35134470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of miRNAs in Childhood Acute Lymphoblastic Leukemia Relapse and the Associated Molecular Mechanisms.
    Barrios-Palacios D; Organista-Nava J; Balandrán JC; Alarcón-Romero LDC; Zubillaga-Guerrero MI; Illades-Aguiar B; Rivas-Alarcón AA; Diaz-Lucas JJ; Gómez-Gómez Y; Leyva-Vázquez MA
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic analysis reveals significant differential expression of miR-378C and miR-128-2-5p in a cohort of relapsed pediatric B-acute lymphoblastic leukemia cases.
    Bhatia P; Singh M; Singh A; Sharma P; Trehan A; Varma N
    Int J Lab Hematol; 2021 Oct; 43(5):1016-1023. PubMed ID: 33538126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-324-3p and miR-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia.
    Zamani A; Fattahi Dolatabadi N; Houshmand M; Nabavizadeh N
    Leuk Res; 2021 Oct; 109():106643. PubMed ID: 34147937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Valiollahi E; Ribera JM; Genescà E; Behravan J
    Mol Biol Rep; 2019 Feb; 46(1):1295-1306. PubMed ID: 30712246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of miR-652-3p and Effect on Apoptosis and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia.
    Jiang Q; Lu X; Huang P; Gao C; Zhao X; Xing T; Li G; Bao S; Zheng H
    Biomed Res Int; 2018; 2018():5724686. PubMed ID: 29967774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia.
    Rzepiel A; Kutszegi N; Gézsi A; Sági JC; Egyed B; Péter G; Butz H; Nyírő G; Müller J; Kovács GT; Szalai C; Semsei ÁF; Erdélyi DJ
    J Transl Med; 2019 Nov; 17(1):372. PubMed ID: 31727091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia.
    Mosakhani N; Missiry ME; Vakkila E; Knuutila S; Vakkila J
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):585-588. PubMed ID: 29068867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia.
    Zhang H; Luo XQ; Zhang P; Huang LB; Zheng YS; Wu J; Zhou H; Qu LH; Xu L; Chen YQ
    PLoS One; 2009 Nov; 4(11):e7826. PubMed ID: 19915715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.
    Verboon LJ; Obulkasim A; de Rooij JD; Katsman-Kuipers JE; Sonneveld E; Baruchel A; Trka J; Reinhardt D; Pieters R; Cloos J; Kaspers GJ; Klusmann JH; Zwaan CM; Fornerod M; van den Heuvel-Eibrink MM
    Oncotarget; 2016 Jul; 7(30):48412-48422. PubMed ID: 27351222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
    Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
    Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
    Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
    Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia.
    Boldrin E; Gaffo E; Niedermayer A; Boer JM; Zimmermann M; Weichenhan D; Claus R; Münch V; Sun Q; Enzenmüller S; Seyfried F; Demir S; Zinngrebe J; Cario G; Schrappe M; Den Boer ML; Plass C; Debatin KM; Te Kronnie G; Bortoluzzi S; Meyer LH
    Blood; 2021 Nov; 138(20):1953-1965. PubMed ID: 34098582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Investigation of miRNome Identifies Novel Candidate miRNA-mRNA Interactions Implicated in T-Cell Acute Lymphoblastic Leukemia.
    Dawidowska M; Jaksik R; Drobna M; Szarzyńska-Zawadzka B; Kosmalska M; Sędek Ł; Machowska L; Lalik A; Lejman M; Ussowicz M; Kałwak K; Kowalczyk JR; Szczepański T; Witt M
    Neoplasia; 2019 Mar; 21(3):294-310. PubMed ID: 30763910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.